Picture of Sartorius Stedim Biotech SA logo

DIM — Sartorius Stedim Biotech SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Brief: Sartorius Stedim Biotech Signs MoU With Sensible Biotechnologies On Cell-Based mRNA Production

July 9 (Reuters) - Sartorius Stedim Biotech SA STDM.PA:

SIGNS MOU WITH SENSIBLE BIOTECHNOLOGIES TO ADVANCE CELL-BASED MRNA PRODUCTION

COLLABORATION AIMS TO ENABLE CLINICAL-GRADE PRODUCTION OF CELL-BASED MRNA BY  2026

Source text: here

Further company coverage: STDM.PA

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Sartorius Stedim Biotech SA

See all news